Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate

Show other versions (1)

Context: Can injectable testosterone undecanoate (TU) be administered effectively and acceptably by the subcutaneous (SC) route? Objective: To investigate the acceptability and pharmacokinetics (PK) of SC injection of TU. Design: Randomized sequence, crossover clinical study of SC vs IM TU injection...

Full description

Bibliographic Details
Main Authors:	Conway, A. (Author), Desai, R. (Author), Fennell, C. (Author), Handelsman, D.J (Author), Handelsman, T.D (Author), Jayadev, V. (Author), Ly, L.P (Author), Savkovic, S. (Author), Singh, G.K.S (Author), Turner, L. (Author)
Format:	Article
Language:	English
Published:	Oxford University Press 2019
Subjects:	adult aged androstanolone area under the curve Article clinical article controlled study crossover procedure dried blood spot testing estradiol female to male transgender human hypogonadism liquid chromatography-mass spectrometry long term care male pain pharmacokinetic parameters pharmacokinetics pharmacology priority journal quality of life randomized controlled trial subcutaneous testosterone testosterone blood level testosterone undecanoate
Online Access:	View Fulltext in Publisher View in Scopus

Similar Items

Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate
by: Conway, A, et al.
Published: (2019)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
by: Nandini Shankara Narayana, et al.
Published: (2021-07-01)

UGT2B17 genotype and the pharmacokinetic serum profile of Testosterone during substitution therapy with Testosterone Undecanoate. A retrospective experience from 207 men with hypogonadism.
by: Anne Kirstine eBang, et al.
Published: (2013-07-01)

Effect of a Combination of Omega-3 and Oral Testosterone Undecanoate On Serum Testosterone Levels in Patients with Testosterone Deficiency
by: Min Gu Park, et al.
Published: (2020-06-01)

Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats
by: Xiao-Wei Zhang, et al.
Published: (2016-01-01)

Effect of a Combination of Dutasteride and Parenteral Testosterone Undecanoate on Testosterone Deficiency Symptoms and Prostate in Patients with Testosterone Efficiency and Benign Prostatic Hyperplasia
by: Min Gu Park, et al.
Published: (2020-06-01)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
by: Yin-Wei Chen, et al.
Published: (2019-01-01)

CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA
by: A. Ya. Kravchenko, et al.
Published: (2016-01-01)

Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2021-01-01)

The long-term effects of testosterone replacement therapy in aging males with late-onset hypogonadism
by: Clausen, Jonathan
Published: (2020)

Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
by: Galina Afanas'evna Melnichenko, et al.
Published: (2017-06-01)

SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking?
by: Stephen J. Winters
Published: (2020-09-01)

Predicting Intestinal and Hepatic First-Pass Metabolism of Orally Administered Testosterone Undecanoate
by: Atheer Zgair, et al.
Published: (2020-10-01)

Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study
by: Jed Kaminetsky, MD, et al.
Published: (2015-12-01)

Androgens and prostate disease
by: Lori A Cooper, et al.
Published: (2014-04-01)

Testosterone therapy with Testopel® and the Esoterix Laboratory assay: A CASE study
by: David Seitman, et al.
Published: (2021-09-01)

Endogenous testosterone and mortality risk
by: Emily J Meyer, et al.
Published: (2018-01-01)

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality
by: Kevin M. Pantalone, et al.
Published: (2019-03-01)

Testosterone Replacement and Bone Mineral Density in Male Pituitary Tumor Patients
by: Min Jeong Lee, et al.
Published: (2014-03-01)

YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy
by: Christopher J. Warren, BA, et al.
Published: (2021-04-01)

The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
by: Yu Seob Shin, et al.
Published: (2019-02-01)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2020-06-01)

The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis
by: Zhichao Zhang, et al.
Published: (2020-03-01)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
by: Kathleen Hwang, et al.
Published: (2015-04-01)

Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy
by: Daniel A Shoskes, et al.
Published: (2015-12-01)

Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events
by: Zelal Jaber Kharaba, et al.
Published: (2020-09-01)

Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene Citrate
by: Sorena Keihani, et al.
Published: (2020-10-01)

Late-onset hypogonadism
by: Piotr Dudek, et al.
Published: (2017-06-01)

Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity
by: María Molina-Vega, et al.
Published: (2018-01-01)

Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)
by: Bhattacharya RK, et al.
Published: (2012-08-01)

Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
by: Xiang Cai, et al.
Published: (2014-02-01)

Late-onset hypogonadism: beyond testosterone
by: Carlo Foresta, et al.
Published: (2015-04-01)

Sex, Energy, Well-Being and Low Testosterone: An Exploratory Survey of U.S. Men’s Experiences on Prescription Testosterone
by: Alex A. Straftis, et al.
Published: (2019-09-01)

Serum Testosterone and Cortisol Concentrations After Single-Dose Administration of 100-Mg Transdermal Testosterone in Healthy Men
by: Andrei A. Puiu, et al.
Published: (2019-11-01)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
by: Borst SE, et al.
Published: (2014-08-01)

Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
by: Katherine Lang Rotker, et al.
Published: (2018-01-01)

Overselling hysteria, dangerously: the media coverage of testosterone therapy in men
by: Vance, Jay
Published: (2016)

Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer
by: George A. M. Lins de Albuquerque, et al.

Emerging Evidences in the Long Standing Controversy Regarding Testosterone Replacement Therapy and Cardiovascular Events
by: Jonathan Clavell-Hernández, et al.
Published: (2018-05-01)

Male hypogonadism (Part 1)
by: Ye.V. Luchytskyy, et al.
Published: (2017-05-01)